AAC (AAC) Cut to “Strong Sell” at ValuEngine

Share on StockTwits

AAC (NYSE:AAC) was downgraded by stock analysts at ValuEngine from a “sell” rating to a “strong sell” rating in a report issued on Thursday, August 30th.

Other equities analysts have also recently issued reports about the company. Cantor Fitzgerald reissued a “buy” rating and set a $14.00 target price on shares of AAC in a research note on Wednesday, May 2nd. Zacks Investment Research cut AAC from a “buy” rating to a “hold” rating in a research note on Tuesday, July 3rd. One equities research analyst has rated the stock with a sell rating, one has assigned a hold rating and three have assigned a buy rating to the stock. The company has a consensus rating of “Hold” and an average target price of $14.00.

NYSE:AAC traded down $0.17 during mid-day trading on Thursday, reaching $7.35. The stock had a trading volume of 162,967 shares, compared to its average volume of 218,300. The company has a debt-to-equity ratio of 2.34, a current ratio of 2.59 and a quick ratio of 2.59. The company has a market capitalization of $186.44 million, a price-to-earnings ratio of 12.25 and a beta of 1.28. AAC has a one year low of $7.07 and a one year high of $12.96.

AAC (NYSE:AAC) last announced its quarterly earnings results on Wednesday, August 1st. The company reported $0.09 EPS for the quarter, missing the Zacks’ consensus estimate of $0.18 by ($0.09). The company had revenue of $86.76 million during the quarter, compared to analysts’ expectations of $82.81 million. AAC had a positive return on equity of 7.32% and a negative net margin of 6.41%. AAC’s revenue for the quarter was up 11.2% on a year-over-year basis. During the same period last year, the firm earned $0.26 earnings per share. sell-side analysts anticipate that AAC will post 0.75 EPS for the current year.

Several hedge funds and other institutional investors have recently added to or reduced their stakes in the stock. Apollo Management Holdings L.P. boosted its holdings in AAC by 102.9% in the second quarter. Apollo Management Holdings L.P. now owns 466,685 shares of the company’s stock worth $4,373,000 after acquiring an additional 236,652 shares in the last quarter. Bank of America Corp DE boosted its holdings in AAC by 2.2% in the second quarter. Bank of America Corp DE now owns 332,301 shares of the company’s stock worth $3,113,000 after acquiring an additional 7,107 shares in the last quarter. Renaissance Technologies LLC boosted its holdings in AAC by 42.3% in the second quarter. Renaissance Technologies LLC now owns 180,680 shares of the company’s stock worth $1,693,000 after acquiring an additional 53,680 shares in the last quarter. BlackRock Inc. lifted its holdings in shares of AAC by 14.3% during the second quarter. BlackRock Inc. now owns 777,117 shares of the company’s stock valued at $7,282,000 after purchasing an additional 97,361 shares in the last quarter. Finally, Spark Investment Management LLC lifted its holdings in shares of AAC by 11.9% during the second quarter. Spark Investment Management LLC now owns 82,600 shares of the company’s stock valued at $773,000 after purchasing an additional 8,800 shares in the last quarter. Institutional investors own 62.21% of the company’s stock.

About AAC

AAC Holdings, Inc provides inpatient and outpatient substance use treatment services for individuals with drug addiction, alcohol addiction, and co-occurring mental/behavioral health issues in the United States. Its therapy services include motivational interviewing, cognitive behavioral therapy, rational emotive behavior therapy, dialectical behavioral therapy, solution-focused therapy, eye movement desensitization and reprocessing, and systematic family intervention.

Further Reading: How to Track your Portfolio in Google Finance

To view ValuEngine’s full report, visit ValuEngine’s official website.

Receive News & Ratings for AAC Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for AAC and related companies with MarketBeat.com's FREE daily email newsletter.

 


Latest News

Yu Darvish Receives Cortisone Shot for Elbow Impingement
Yu Darvish Receives Cortisone Shot for Elbow Impingement
Red Sox and Brandon Phillips Agree to Minor League Deal
Red Sox and Brandon Phillips Agree to Minor League Deal
Chris Sale Proves He is 2018 AL Cy Young Candidate
Chris Sale Proves He is 2018 AL Cy Young Candidate
Strong Results by Clint Frazier Could Keep Him with Yankees
Strong Results by Clint Frazier Could Keep Him with Yankees
Giants Closer Breaks Hand Punching Door Following Poor Outing
Giants Closer Breaks Hand Punching Door Following Poor Outing
Evan Longoria Out Six to Eight Weeks With Broken Hand
Evan Longoria Out Six to Eight Weeks With Broken Hand


Leave a Reply

 
© 2006-2018 BBNS.